FDA states that it has analyzed this rule in accordance with the principles set forth in Executive Order 12612, Federalism, and has determined that the rule does not warrant the preparation of a Federalism Assessment.
The Food and Drug Administration has found that there is no need for a Federal Assessment in this situation.